Data shows reduction of microglia activation and improvement in behavior in rodent model of Alzheimer's disease (AD)Modulation of neuroinflammation may be synergistic to existing treatments in AD NEW
AriBio Co., Ltd. announced that David Greeley MD, Chief Medical Officer at AriBio, will present biomarker data from the completed phase 2 study in patients with mild to moderate Alzheimer's disease
A new study in Bangladesh has found that women who were hospitalised with severe cases of the novel coronavirus are experiencing more post-COVID complications than men.
BRENTWOOD, Tenn. and LAKEWOOD RANCH, Fla., March 20, 2023 (GLOBE NEWSWIRE) via InvestorWire IMAC Holdings, Inc. ("IMAC") (Nasdaq: BACK), a regenerative rehabilitation company focused on treating